ROPEOK Technology Group Full Year 2023 Earnings CN0.25 loss per share - Simply Wall St
| 688619 Stock | 8.17 0.45 5.22% |
About 61% of ROPEOK Technology's investor base is looking to short. The analysis of the overall prospects from investing in ROPEOK Technology Group suggests that many traders are, at the present time, alarmed. The current market sentiment, together with ROPEOK Technology's historical and current headlines, can help investors time the market. In addition, many technical investors use ROPEOK Technology stock news signals to limit their universe of possible portfolio assets.
ROPEOK |
ROPEOK Technology Group Full Year 2023 Earnings CN0.25 loss per share Simply Wall St
Read at news.google.com
 |
ROPEOK Technology Fundamental Analysis
We analyze ROPEOK Technology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ROPEOK Technology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ROPEOK Technology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
ROPEOK Technology is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
ROPEOK Technology Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ROPEOK Technology stock to make a market-neutral strategy. Peer analysis of ROPEOK Technology could also be used in its relative valuation, which is a method of valuing ROPEOK Technology by comparing valuation metrics with similar companies.
Peers
ROPEOK Technology Related Equities
| 603993 | China Molybdenum | 2.89 | ||||
| 688072 | Piotech | 0.89 | ||||
| 688126 | National Silicon | 0.22 | ||||
| 601628 | China Life | 1.26 | ||||
| 600383 | Gemdale Corp | 1.37 | ||||
| 688293 | Shanghai OPM | 1.43 | ||||
| 601198 | Dongxing Sec | 2.80 | ||||
| 601059 | Cinda Securities | 2.94 |
Complementary Tools for ROPEOK Stock analysis
When running ROPEOK Technology's price analysis, check to measure ROPEOK Technology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ROPEOK Technology is operating at the current time. Most of ROPEOK Technology's value examination focuses on studying past and present price action to predict the probability of ROPEOK Technology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ROPEOK Technology's price. Additionally, you may evaluate how the addition of ROPEOK Technology to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |